Oral Nifidepine versus IV labetalol in severe preeclampsia: A randomized control trial

OBJECTIVE: To compare oral Nifidepine and IV labetalol in terms of rapidity of BP control in severe preeclampsia. METHODS: All patients coming to Services Hospital from March 2017 to February 2019 with diagnosis of severe preeclampsia ≥ 24 weeks gestation were randomized to either receive Nifidepine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasim, Tayyiba, Agha, Shazia, Saeed, Kanwal, Riaz, Anam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500996/
https://www.ncbi.nlm.nih.gov/pubmed/32968371
http://dx.doi.org/10.12669/pjms.36.6.2591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500996/
https://www.ncbi.nlm.nih.gov/pubmed/32968371
http://dx.doi.org/10.12669/pjms.36.6.2591

Ejemplares similares